Johnson & Johnson Price to Book Ratio 2006-2019 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of July 16, 2019 is 6.07.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2019-07-16 |
132.50 |
|
5.97 |
| 2019-03-31 |
139.79 |
$22.20 |
6.30 |
| 2018-12-31 |
128.20 |
$22.44 |
5.71 |
| 2018-09-30 |
136.39 |
$24.09 |
5.66 |
| 2018-06-30 |
118.99 |
$23.45 |
5.07 |
| 2018-03-31 |
124.74 |
$23.58 |
5.29 |
| 2017-12-31 |
135.14 |
$22.43 |
6.03 |
| 2017-09-30 |
124.99 |
$27.55 |
4.54 |
| 2017-06-30 |
126.38 |
$26.78 |
4.72 |
| 2017-03-31 |
118.20 |
$26.10 |
4.53 |
| 2016-12-31 |
108.63 |
$26.02 |
4.18 |
| 2016-09-30 |
110.62 |
$26.73 |
4.14 |
| 2016-06-30 |
112.83 |
$26.47 |
4.26 |
| 2016-03-31 |
99.94 |
$26.40 |
3.79 |
| 2015-12-31 |
94.20 |
$25.82 |
3.65 |
| 2015-09-30 |
84.98 |
$25.86 |
3.29 |
| 2015-06-30 |
88.03 |
$25.69 |
3.43 |
| 2015-03-31 |
90.21 |
$24.45 |
3.69 |
| 2014-12-31 |
93.12 |
$25.06 |
3.72 |
| 2014-09-30 |
94.31 |
$27.31 |
3.45 |
| 2014-06-30 |
91.94 |
$27.65 |
3.32 |
| 2014-03-31 |
85.73 |
$27.08 |
3.17 |
| 2013-12-31 |
79.36 |
$26.25 |
3.02 |
| 2013-09-30 |
74.60 |
$24.75 |
3.01 |
| 2013-06-30 |
73.34 |
$24.75 |
2.96 |
| 2013-03-31 |
69.12 |
$23.85 |
2.90 |
| 2012-12-31 |
58.96 |
$23.33 |
2.53 |
| 2012-09-30 |
57.45 |
$23.08 |
2.49 |
| 2012-06-30 |
55.82 |
$21.97 |
2.54 |
| 2012-03-31 |
53.98 |
$22.35 |
2.42 |
| 2011-12-31 |
53.20 |
$20.95 |
2.54 |
| 2011-09-30 |
51.19 |
$22.52 |
2.27 |
| 2011-06-30 |
52.99 |
$22.67 |
2.34 |
| 2011-03-31 |
46.79 |
$21.86 |
2.14 |
| 2010-12-31 |
48.41 |
$20.66 |
2.34 |
| 2010-09-30 |
48.08 |
$20.85 |
2.31 |
| 2010-06-30 |
45.40 |
$19.19 |
2.37 |
| 2010-03-31 |
49.67 |
$19.19 |
2.59 |
| 2009-12-31 |
48.69 |
$18.37 |
2.65 |
| 2009-09-30 |
45.67 |
$18.27 |
2.50 |
| 2009-06-30 |
42.26 |
$16.79 |
2.52 |
| 2009-03-31 |
38.79 |
$15.87 |
2.44 |
| 2008-12-31 |
43.76 |
$15.35 |
2.85 |
| 2008-09-30 |
50.27 |
$16.45 |
3.06 |
| 2008-06-30 |
46.39 |
$16.61 |
2.79 |
| 2008-03-31 |
46.44 |
$16.19 |
2.87 |
| 2007-12-31 |
47.44 |
$15.25 |
3.11 |
| 2007-09-30 |
46.44 |
$15.17 |
3.06 |
| 2007-06-30 |
43.27 |
$14.90 |
2.90 |
| 2007-03-31 |
42.04 |
$14.14 |
2.97 |
| 2006-12-31 |
45.79 |
$13.59 |
3.37 |
| 2006-09-30 |
44.79 |
$13.97 |
3.21 |
| 2006-06-30 |
41.09 |
$13.89 |
2.96 |
| 2006-03-31 |
40.36 |
$13.83 |
2.92 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$357.663B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
